NOVARTIS-MIT

The Novartis-MIT Center for Continuous Manufacturing is a 10-year research collaboration aimed at transforming pharmaceutical production. Combining the industrial expertise of Novartis with MIT's scientific and technological leadership, the Center develops new technologies to replace the pharmaceutical industry's conventional batch-based system with a continuous manufacturing process... Initial research is conducted primarily through PhD programs at MIT laboratories and involves MIT faculty members, students, postdoctoral fellows, and staff scientists. Novartis then applies the research to industrial-scale projects and pilots new manufacturing processes using its own pharmaceutical products. Novartis has committed its manufacturing and R&D resources and $65 million to the Center over the next 10 years.

Also known as: Novartis, Novartis-MIT Center for Continuous Manufacturing

Primary location: Cambridge United States